Dimethylformamide → HCID 178494340, compound

HRID 1791795Notes

Reaction equation

HRID 1791795 reaction equation
CO[C:3]1[CH:4]=[C:5]2[C:10](=[CH:11][C:12]=1[O:13][CH2:14][C@H:15]1[CH2:17][O:16]1)[N:9]=[CH:8][N:7]=[C:6]2[O:18][C:19]1[CH:20]=[C:21]2[C:25](=[CH:26][CH:27]=1)[NH:24][CH:23]=[C:22]2[CH3:28].[NH:29]1[CH2:34][CH2:33][O:32][CH2:31][CH2:30]1.CN([CH:38]=[O:39])C>>[OH:16][C@H:15]([CH2:17][N:29]1[CH2:34][CH2:33][O:32][CH2:31][CH2:30]1)[CH2:14][O:13][C:12]1[CH:11]=[C:10]2[C:5]([C:6]([O:39][CH3:38])([O:18][C:19]3[CH:20]=[C:21]4[C:25](=[CH:26][CH:27]=3)[NH:24][CH:23]=[C:22]4[CH3:28])[NH:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1

Participants

4

Reactant 3

HCID 6228DimethylformamideHCID 8083MorpholineHCID 54069082(2R)-6-methoxy-4-(3-methylindol-5-yloxy)-7-(oxiran-2-ylmethoxy)quinazoline

Product 1

HCID 178494340HCID 178494340, compoundYield 93%

Conditions

Temperature
60 °C

Procedure

A mixture of (2R)-6-methoxy-4-(3-methylindol-5-yloxy)-7-(oxiran-2-ylmethoxy)quinazoline (350 mg, 0.93 mmol), (prepared as described in Example 278), and morpholine (0.24 ml, 2.78 mmol) in DMF (5 ml) was stirred at 60° C. for 24 hours and allowed to cool to ambient temperature. The solvents were removed in vacuo and the residue purified by silica column chromatography using gradient elution (dichloromethane, 5% methanol/95% dichloromethane, methanol/dichloromethane/0.880 saturated aqueous ammonia (100/8/1)) to give (2R)-7-(2-hydroxy-3-morpholinopropoxy)-4-methoxy-4-(3-methylindol-5-yloxy)quinazoline (398 mg, 93%).

Workup

  1. temperatureto cool to ambient temperature
  2. customThe solvents were removed in vacuo
  3. customthe residue purified by silica column chromatography
  4. washelution (dichloromethane, 5% methanol/95% dichloromethane, methanol/dichloromethane/0.880 saturated aqueous ammonia (100/8/1))

Sources & evidence

ORD record
ord-1073a0acd8fd49f589f14c410c5a7776
Source dataset
uspto-grants-2006_07
Patent number
US07074800B1

Reaction notes

Loading…